National Heart Foundation of Australia, 850 Collins Street, Melbourne VIC 3000, Australia.
Royal Melbourne Hospital, 300 Grattan Street, Parkville 3050, Australia.
Eur J Cardiovasc Nurs. 2024 Mar 12;23(2):107-114. doi: 10.1093/eurjcn/zvad048.
Women are underrepresented in cardiovascular trials. We sought to explore the proportional representation of women in contemporary cardiovascular research and the factors (barriers and enablers) that affect their participation in cardiovascular studies.
Multiple electronic databases were searched between January 2011 and September 2021 to identify papers that defined underrepresentation of women in cardiovascular research and/or reported sex-based differences in participating in cardiovascular research and/or barriers for women to participate in cardiovascular research. Data extraction was undertaken independently by two authors using a standardised data collection form. Results were summarised using descriptive statistics and narrative synthesis as appropriate.From 548 identified papers, 10 papers were included. Of those, four were conducted prospectively and six were retrospective studies. Five of the retrospective studies involved secondary analysis of trial data including over 780 trials in over 1.1 million participants. Overall, women were reported to be underrepresented in heart failure, coronary disease, myocardial infarction, and arrhythmia trials, compared to men. Barriers to participation included lack of information and understanding of the research, trial-related procedures, the perceived health status of the participant, and patient-specific factors including travel, childcare availability, and cost. A significantly higher likelihood of research participation was reported by women following a patient educational intervention.
This review has highlighted the underrepresentation of women in a range of cardiovascular trials. Several barriers to women's participation in cardiovascular studies were identified. Researchers could mitigate against these in future trial planning and delivery to increase women's participation in cardiovascular research.
The protocol was published on the public Open Science Framework platform on 13th August 2021 (no registration reference provided) and can be accessed at https://osf.io/ny4fd/.
女性在心血管试验中的代表性不足。本研究旨在探讨当代心血管研究中女性的代表性比例,以及影响女性参与心血管研究的因素(障碍和促进因素)。
2011 年 1 月至 2021 年 9 月期间,我们通过多个电子数据库检索了定义心血管研究中女性代表性不足以及/或报告女性参与心血管研究中性别差异和/或女性参与心血管研究障碍的论文。两位作者使用标准化数据采集表独立进行数据提取。结果采用描述性统计和叙述性综合进行总结。从 548 篇确定的论文中,纳入了 10 篇论文。其中,4 项为前瞻性研究,6 项为回顾性研究。6 项回顾性研究中有 5 项涉及临床试验数据的二次分析,包括超过 780 项临床试验,涉及超过 110 万名参与者。与男性相比,女性在心力衰竭、冠心病、心肌梗死和心律失常试验中的代表性不足。参与障碍包括缺乏对研究、试验相关程序、参与者健康状况的了解和认识,以及患者特定因素,包括旅行、儿童保育可用性和费用。研究报告称,女性在接受患者教育干预后更有可能参与研究。
本综述强调了女性在一系列心血管试验中代表性不足的问题。确定了女性参与心血管研究的几个障碍。研究人员可以在未来的试验规划和实施中加以解决,以增加女性在心血管研究中的参与度。
该方案于 2021 年 8 月 13 日在公共开放科学框架平台上发布(未提供注册参考),可在 https://osf.io/ny4fd/ 上访问。